Notwithstanding the multiple systematic meta-analysis that addressed the impact of Sox2 [40], nestin [41], and vimentin [42] as independent predictors in human lung cancer prognosis, two reports demonstrated the clinicopathological and prognostic significance of the nucleolin expression in lung cancer patients. The gene discussed is VIM; the disease is lung carcinoma.